Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.

R. Desrosiers

Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.

Research output: Contribution to journal › Article

Abstract

Dr. Ronald Desrosiers of the New England Primate Research Center at the Harvard Medical School provides his opinions on the HIV-1deltakURNe vaccine strain. Dr. Desrosiers explains what this strain represents and how it was chosen for live-attenuated HIV vaccine human safety trials. Further, Desrosiers discusses the balance in using highly attenuated vaccines and protection effectiveness, whether it is possible for the vaccine strain to revert to a disease-causing form, the possibility of transmission of a vaccine virus to unvaccinated individuals, and the issue of cancer development through insertional mutagenesis.

Original language	English (US)
Pages (from-to)	45-46
Number of pages	2
Journal	Journal of the International Association of Physicians in AIDS Care
Volume	4
Issue number	3
State	Published - Mar 1998
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

Fingerprint Dive into the research topics of 'Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.'. Together they form a unique fingerprint.

Cite this

Desrosiers, R. (1998). Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD. Journal of the International Association of Physicians in AIDS Care, 4(3), 45-46.

@article{7610e06ce6054e01a634de3206d25b52,

title = "Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.",

abstract = "Dr. Ronald Desrosiers of the New England Primate Research Center at the Harvard Medical School provides his opinions on the HIV-1deltakURNe vaccine strain. Dr. Desrosiers explains what this strain represents and how it was chosen for live-attenuated HIV vaccine human safety trials. Further, Desrosiers discusses the balance in using highly attenuated vaccines and protection effectiveness, whether it is possible for the vaccine strain to revert to a disease-causing form, the possibility of transmission of a vaccine virus to unvaccinated individuals, and the issue of cancer development through insertional mutagenesis.",

author = "R. Desrosiers",

year = "1998",

month = mar,

language = "English (US)",

volume = "4",

pages = "45--46",

journal = "Journal of the International Association of Physicians in AIDS Care",

issn = "1081-454X",

publisher = "SAGE Publications Inc.",

number = "3",

}

TY - JOUR

T1 - Does the HIV-1deltakURNe vaccine strain hold the key to curbing HIV infection? An interview with Ronald Desrosiers, PhD.

AU - Desrosiers, R.

PY - 1998/3

Y1 - 1998/3

N2 - Dr. Ronald Desrosiers of the New England Primate Research Center at the Harvard Medical School provides his opinions on the HIV-1deltakURNe vaccine strain. Dr. Desrosiers explains what this strain represents and how it was chosen for live-attenuated HIV vaccine human safety trials. Further, Desrosiers discusses the balance in using highly attenuated vaccines and protection effectiveness, whether it is possible for the vaccine strain to revert to a disease-causing form, the possibility of transmission of a vaccine virus to unvaccinated individuals, and the issue of cancer development through insertional mutagenesis.

AB - Dr. Ronald Desrosiers of the New England Primate Research Center at the Harvard Medical School provides his opinions on the HIV-1deltakURNe vaccine strain. Dr. Desrosiers explains what this strain represents and how it was chosen for live-attenuated HIV vaccine human safety trials. Further, Desrosiers discusses the balance in using highly attenuated vaccines and protection effectiveness, whether it is possible for the vaccine strain to revert to a disease-causing form, the possibility of transmission of a vaccine virus to unvaccinated individuals, and the issue of cancer development through insertional mutagenesis.

UR - http://www.scopus.com/inward/record.url?scp=0032015693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032015693&partnerID=8YFLogxK

M3 - Article

C2 - 11365180

AN - SCOPUS:0032015693

VL - 4

SP - 45

EP - 46

JO - Journal of the International Association of Physicians in AIDS Care

JF - Journal of the International Association of Physicians in AIDS Care

SN - 1081-454X

IS - 3

ER -